Investors and Media

Press Releases

September 9, 2020

Scholar Rock Announces First Patient Dosed in Part A2 of DRAGON Phase 1 Proof-of-Concept Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy

September 2, 2020

Scholar Rock to Present at Upcoming Healthcare Conferences

August 27, 2020

Scholar Rock Announces Issuance of U.S. Patent Providing Composition of Matter Protection for SRK-015

August 13, 2020

Scholar Rock Announces that SRK-015 has Received Rare Pediatric Disease Designation from U.S. FDA for the Treatment of Spinal Muscular Atrophy

August 7, 2020

Scholar Rock Reports Second Quarter 2020 Financial Results and Highlights Business Progress

August 5, 2020

Scholar Rock to Present at the 2020 Wedbush PacGrow Healthcare Conference

August 3, 2020

Scholar Rock to Announce Second Quarter 2020 Financial Results and Introduce Newest Members of Management August 7, 2020

July 16, 2020

Scholar Rock Appoints Edward (Ted) Myles as Chief Financial Officer and Head of Business Operations

Archived Press Releases